Last $1.43 USD
Change Today +0.02 / 1.42%
Volume 1.1M
DVAX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Denise M. Gilbert Ph.D.

Director and Chairman of Audit Committee, Cytokinetics, Incorporated
AgeTotal Calculated CompensationThis person is connected to 45 board members in 3 different organizations across 4 different industries.

See Board Relationships
56$73,567

Background*

Dr. Denise M. Gilbert, Ph.D., is an Independent Consultant and Strategic Advisor to life science companies. Dr. Gilbert has over 20 years of experience in the life science industry. She served as the Chief Executive Officer of Entigen Corporation from 2001 to 2002. Dr. Gilbert served as the Chief Financial Officer and Executive Vice President of Incyte Pharmaceuticals (now Incyte Genomics) from 1995 to 1999 and Chief Financial Officer and Executive Vice President at ...

Read Full Background

Corporate Headquarters*

2929 Seventh Street
Berkeley, California 94710

United States

Phone: 510-848-5100
Fax: --

Board Members Memberships*

Former Director
2003-N/A
Former Director and Chairman of Audit Committee
2004-Present
Director and Chairperson of Audit Committee
2008-Present
Director and Chairman of Audit Committee
2008-Present
Director and Chairman of Audit Committee

Education*

BS
Cornell University
PhD
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options20,762
Unexercisable Options1,736
Total Number of Options22,498

Total Compensation*

Total Annual Cash Compensation$55,000
Total Calculated Compensation$73,567
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVAX:US $1.43 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$366.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYNAVAX TECHNOLOGIES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.